DRZID
CVS icon

DePrince Race & Zollo Inc (DRZ)’s CVS Health CVS Stock Holding History

DePrince Race & Zollo Inc (DRZ)’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-465,970
Closed -$36.8M – 180
2023
Q4 		$36.8M Sell
465,970
-35,565
-7% -$2.53M 0.83% 38
2023
Q3 		$35M Buy
501,535
+52,588
+12% +$3.73M 0.85% 34
2023
Q2 		$31M Buy
448,947
+17,728
+4% +$1.26M 0.71% 47
2023
Q1 		$32M Buy
431,219
+121,116
+39% +$10.2M 0.74% 51
2022
Q4 		$28.9M Buy
310,103
+17,932
+6% +$1.73M 0.66% 69
2022
Q3 		$27.9M Buy
292,171
+43,431
+17% +$4.3M 0.71% 58
2022
Q2 		$23M Sell
248,740
-704
-0.3% -$68.7K 0.53% 93
2022
Q1 		$25.2M Sell
249,444
-159,057
-39% -$16.7M 0.49% 103
2021
Q4 		$42.1M Sell
408,501
-6,386
-2% -$590K 1.07% 11
2021
Q3 		$35.2M Sell
414,887
-7,480
-2% -$627K 0.94% 19
2021
Q2 		$35.2M Buy
422,367
+29,840
+8% +$2.44M 0.89% 19
2021
Q1 		$29.5M Buy
392,527
+11,530
+3% +$840K 0.79% 35
2020
Q4 		$26M Buy
380,997
+12,851
+3% +$836K 0.82% 32
2020
Q3 		$21.5M Buy
368,146
+36,439
+11% +$2.27M 0.81% 38
2020
Q2 		$21.6M Buy
331,707
+52,540
+19% +$3.31M 0.84% 34
2020
Q1 		$16.6M Buy
279,167
+960
+0.3% +$64.1K 0.76% 46
2019
Q4 		$20.7M Sell
278,207
-36,865
-12% -$2.59M 0.63% 63
2019
Q3 		$19.9M Sell
315,072
-890
-0.3% -$52.7K 0.57% 85
2019
Q2 		$17.2M Sell
315,962
-4,940
-2% -$266K 0.48% 105
2019
Q1 		$17.3M Buy
320,902
+20,443
+7% +$1.26M 0.47% 104
2018
Q4 		$19.7M Sell
300,459
-49,560
-14% -$3.7M 0.57% 75
2018
Q3 		$27.6M Sell
350,019
-16,853
-5% -$1.2M 0.62% 61
2018
Q2 		$23.6M Sell
366,872
-20,260
-5% -$1.34M 0.55% 70
2018
Q1 		$24.1M Sell
387,132
-3,701
-0.9% -$266K 0.56% 78
2017
Q4 		$28.3M Sell
390,833
-16,800
-4% -$1.22M 0.63% 66
2017
Q3 		$33.1M Sell
407,633
-121,041
-23% -$9.57M 0.74% 42
2017
Q2 		$42.5M Buy
528,674
+53,128
+11% +$4.19M 0.87% 28
2017
Q1 		$37.3M Sell
475,546
-9,235
-2% -$737K 0.77% 40
2016
Q4 		$38.3M Buy
+484,781
New +$39.2M 0.75% 47

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ)'s CVS Position: Q1 2024 in Review

DePrince Race & Zollo Inc (DRZ) sold out of CVS Health (CVS) in Q1 2024, closing a stake of 465,970 shares — an estimated $36.8M sold.

DePrince Race & Zollo Inc (DRZ) first reported a position in CVS in Q4 2016 and held it in 29 quarters. The position peaked at $42.5M in Q2 2017. 2,178 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • DePrince Race & Zollo Inc (DRZ) reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • DePrince Race & Zollo Inc (DRZ) sold 465,970 CVS Health shares in Q1 2024, an estimated $36.8M.
  • DePrince Race & Zollo Inc (DRZ) first reported a position in CVS Health in Q4 2016 and held it in 29 quarters.
  • DePrince Race & Zollo Inc (DRZ)'s CVS Health position peaked at $42.5M in Q2 2017.
  • 2,178 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q1 2024, filed 15 May 2024.